Joshua R. Hansen

Joshua R. Hansen

Auto-generated profile, based on publicly available information

Joshua R. Hansen

Pacific Northwest National Laboratory

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in Nature
Verified
Journal Article
Open access
PDF file
MGMoTrPAC Study Group
MoTrPAC Study Group
LALead Analysts
Lead Analysts
DADavid Amar
David Amar
NGNicole R. Gay
Nicole R. Gay
PJPierre M. Jean-Beltran
Pierre M. Jean-Beltran
EVElena Volpi
Elena Volpi
Regular exercise promotes whole-body health and prevents disease, but the underlying molecular mechanisms are incompletely understood1–3. Here, the Molecular Transducers of Physical Activity Consortium4 profiled the temporal transcriptome, proteome, metabolome, lipidome, phosphoproteome, acetylproteome, ubiquitylproteome, epigenome and immunome in whole blood, plasma and 18 solid tissues in male and female Rattus norvegicus over eight weeks of endurance exercise training. The resulting data compendium encompasses 9,466 assays across 19 tissues, 25 molecular platforms and 4 training time points. Thousands of shared and tissue-specific molecular alterations were identified, with sex differences found in multiple tissues. Temporal multi-omic and multi-tissue analyses revealed expansive biological insights into the adaptive responses to endurance training, including widespread regulation of immune, metabolic, stress response and mitochondrial pathways. Many changes were relevant to human health, including non-alcoholic fatty liver disease, inflammatory bowel disease, cardiovascular health and tissue injury and recovery. The data and analyses presented in this study will serve as valuable resources for understanding and exploring the multi-tissue molecular effects of endurance training and are provided in a public repository (https://motrpac-data.org/).

13 December 2018 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CWChristopher Whidbey
Christopher Whidbey
NSNatalie C. Sadler
Natalie C. Sadler
RNReji N. Nair
Reji N. Nair
RVRegan F. Volk
Regan F. Volk
ADAdrian J. DeLeon
Adrian J. DeLeon
Aaron T. WrightAaron T. Wright
Aaron T. Wright

3 April 2019 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
MDMary S Dickinson
Mary S Dickinson
LALindsey N Anderson
Lindsey N Anderson
BWBobbie-Jo Webb-Robertson
Bobbie-Jo Webb-Robertson
JHJoshua R Hansen
Joshua R Hansen
RSRichard D Smith
Richard D Smith
KHKevin Hybiske
Kevin Hybiske
Chlamydia trachomatis is the most common cause of bacterial sexually transmitted infection, responsible for millions of infections each year. Despite this high prevalence, the elucidation of the molecular mechanisms of Chlamydia pathogenesis has been difficult due to limitations in genetic tools and its intracellular developmental cycle. Within a host epithelial cell, chlamydiae replicate within a vacuole called the inclusion. Many Chlamydia–host interactions are thought to be mediated by the Inc family of type III secreted proteins that are anchored in the inclusion membrane, but their array of host targets are largely unknown. To investigate how the inclusion membrane proteome changes over the course of an infected cell, we have adapted the APEX2 system of proximity-dependent biotinylation. APEX2 is capable of specifically labeling proteins within a 20 nm radius in living cells. We transformed C. trachomatis to express the enzyme APEX2 fused to known inclusion membrane proteins, allowing biotinylation and purification of inclusion-associated proteins. Using quantitative mass spectrometry against APEX2 labeled samples, we identified over 400 proteins associated with the inclusion membrane at early, middle, and late stages of epithelial cell infection. This system was sensitive enough to detect inclusion interacting proteins early in the developmental cycle, at 8 hours post infection, a previously intractable time point. Mass spectrometry analysis revealed a novel, early association between C. trachomatis inclusions and endoplasmic reticulum exit sites (ERES), functional regions of the ER where COPII-coated vesicles originate. Pharmacological and genetic disruption of ERES function severely restricted early chlamydial growth and the development of infectious progeny. APEX2 is therefore a powerful in situ approach for identifying critical protein interactions on the membranes of pathogen-containing vacuoles. Furthermore, the data derived from proteomic mapping of Chlamydia inclusions has illuminated an important functional role for ERES in promoting chlamydial developmental growth. Chlamydia are obligate intracellular bacteria that require the establishment and maintenance of a host vacuole (the inclusion) for their developmental growth. Chlamydiae modify the inclusion membrane through the secretion of type III membrane proteins and recruited host factors. These membrane modifications are predicted to transform the inclusion into a favorable replicating environment through the host protein networks they interact with. Despite the essentiality of the inclusion for Chlamydia, only a preliminary understanding exists concerning its membrane protein composition. In particular, the early mechanisms controlling the biogenesis of the inclusion are poorly understood. To develop a deeper understanding of the inclusion membrane interaction proteome, we capitalized on recent advances in Chlamydia genetics to express and localize a proximity-dependent biotinylation tag onto type III secreted inclusion membrane proteins. We then applied this system to identify by mass spectrometry the major host and chlamydial proteins recruited to early, mid, and late stage inclusion membranes of C. trachomatis infected cells. Interestingly, proteomic data showed enrichments of proteins with characterized roles in regulating endoplasmic reticulum exit sites (ERES). Functional testing through protein knockdown and pharmacological inhibition demonstrated that interactions between early C. trachomatis inclusions and ERES are critical for promoting the developmental growth of Chlamydia.

6 May 2021 in ACS Omega
Verified
Journal Article
Open access
CHChelsea Hutchinson-Bunch
Chelsea Hutchinson-Bunch
JSJames A. Sanford
James A. Sanford
JHJoshua R. Hansen
Joshua R. Hansen
MGMarina A Gritsenko
Marina A Gritsenko
KRKarin Rodland
Karin Rodland
JAJoshua N. Adkins
Joshua N. Adkins
Isobaric labeling via tandem mass tag (TMT) reagents enables sample multiplexing prior to LC–MS/MS, facilitating high-throughput large-scale quantitative proteomics. Consistent and efficient labeling reactions are essential to achieve robust quantification; therefore, embedded in our clinical proteomic protocol is a quality control (QC) sample that contains a small aliquot from each sample within a TMT set, referred to as “Mixing QC.” This Mixing QC enables the detection of TMT labeling issues by LC–MS/MS before combining the full samples to allow for salvaging of poor TMT labeling reactions. While TMT labeling is a valuable tool, factors leading to poor reactions are not fully studied. We observed that relabeling does not necessarily rescue TMT reactions and that peptide samples sometimes remained acidic after resuspending in 50 mM HEPES buffer (pH 8.5), which coincided with low labeling efficiency (LE) and relatively low median reporter ion intensities (MRIIs). To obtain a more resilient TMT labeling procedure, we investigated LE, reporter ion missingness, the ratio of mean TMT set MRII to individual channel MRII, and the distribution of log 2 reporter ion ratios of Mixing QC samples. We discovered that sample pH is a critical factor in LE, and increasing the buffer concentration in poorly labeled samples before relabeling resulted in the successful rescue of TMT labeling reactions. Moreover, resuspending peptides in 500 mM HEPES buffer for TMT labeling resulted in consistently higher LE and lower missing data. By better controlling the sample pH for labeling and implementing multiple methods for assessing labeling quality before combining samples, we demonstrate that robust TMT labeling for large-scale quantitative studies is achievable.

7 March 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
RMRucha V. Modak
Rucha V. Modak
KRKatia G. de Oliveira Rebola
Katia G. de Oliveira Rebola
JMJohn McClatchy
John McClatchy
MMMona Mohammadhosseini
Mona Mohammadhosseini
ADAlisa Damnernsawad
Alisa Damnernsawad
AAAnupriya Agarwal
Anupriya Agarwal
Purpose: Emerging evidence underscores the critical role of extrinsic factors within the microenvironment in protecting leukemia cells from therapeutic interventions, driving disease progression, and promoting drug resistance in acute myeloid leukemia (AML). This finding emphasizes the need for the identification of targeted therapies that inhibit intrinsic and extrinsic signaling to overcome drug resistance in AML. Experimental Design: We performed a comprehensive analysis utilizing a cohort of ∼300 AML patient samples. This analysis encompassed the evaluation of secreted cytokines/growth factors, gene expression, and ex vivo drug sensitivity to small molecules. Our investigation pinpointed a notable association between elevated levels of CCL2 and diminished sensitivity to the MEK inhibitors (MEKi). We validated this association through loss-of-function and pharmacologic inhibition studies. Further, we deployed global phosphoproteomics and CRISPR/Cas9 screening to identify the mechanism of CCR2-mediated MEKi resistance in AML. Results: Our multifaceted analysis unveiled that CCL2 activates multiple prosurvival pathways, including MAPK and cell-cycle regulation in MEKi-resistant cells. Employing combination strategies to simultaneously target these pathways heightened growth inhibition in AML cells. Both genetic and pharmacologic inhibition of CCR2 sensitized AML cells to trametinib, suppressing proliferation while enhancing apoptosis. These findings underscore a new role for CCL2 in MEKi resistance, offering combination therapies as an avenue to circumvent this resistance. Conclusions: Our study demonstrates a compelling rationale for translating CCL2/CCR2 axis inhibitors in combination with MEK pathway-targeting therapies, as a potent strategy for combating drug resistance in AML. This approach has the potential to enhance the efficacy of treatments to improve AML patient outcomes.

23 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
MGMoTrPAC Study Group
MoTrPAC Study Group
DADavid Amar
David Amar
NGNicole R. Gay
Nicole R. Gay
PBPierre M. Jean Beltran
Pierre M. Jean Beltran
JAJoshua N. Adkins
Joshua N. Adkins
MWMatthew T. Wheeler
Matthew T. Wheeler
Regular exercise promotes whole-body health and prevents disease, yet the underlying molecular mechanisms throughout a whole organism are incompletely understood. Here, the Molecular Transducers of Physical Activity Consortium (MoTrPAC) profiled the temporal transcriptome, proteome, metabolome, lipidome, phosphoproteome, acetylproteome, ubiquitylproteome, epigenome, and immunome in whole blood, plasma, and 18 solid tissues in Rattus norvegicus over 8 weeks of endurance exercise training. The resulting data compendium encompasses 9466 assays across 19 tissues, 25 molecular platforms, and 4 training time points in young adult male and female rats. We identified thousands of shared and tissue- and sex-specific molecular alterations. Temporal multi-omic and multi-tissue analyses demonstrated distinct patterns of tissue remodeling, with widespread regulation of immune, metabolism, heat shock stress response, and mitochondrial pathways. These patterns provide biological insights into the adaptive responses to endurance training over time. For example, exercise training induced heart remodeling via altered activity of the Mef2 family of transcription factors and tyrosine kinases. Translational analyses revealed changes that are consistent with human endurance training data and negatively correlated with disease, including increased phospholipids and decreased triacylglycerols in the liver. Sex differences in training adaptation were widespread, including those in the brain, adrenal gland, lung, and adipose tissue. Integrative analyses generated novel hypotheses of disease relevance, including candidate mechanisms that link training adaptation to non-alcoholic fatty liver disease, inflammatory bowel disease, cardiovascular health, and tissue injury and recovery. The data and analysis results presented in this study will serve as valuable resources for the broader community and are provided in an easily accessible public repository ( https://motrpac-data.org/ ). Highlights: Multi-tissue resource identifies 35,439 analytes regulated by endurance exercise training at 5% FDR across 211 combinations of tissues and molecular platforms. Interpretation of systemic and tissue-specific molecular adaptations produced hypotheses to help describe the health benefits induced by exercise. Robust sex-specific responses to endurance exercise training are observed across multiple organs at the molecular level. Deep multi-omic profiling of six tissues defines regulatory signals for tissue adaptation to endurance exercise training. All data are available in a public repository, and processed data, analysis results, and code to reproduce major analyses are additionally available in convenient R packages.